NeuroSense Therapeutics Ltd. (NRSN, NRSNW)

CIK 1875091 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for NeuroSense Therapeutics Ltd..

Recent SEC filings

FiledFormAccession number
Sep 9, 20266-K0001213900-26-098414
Aug 27, 20266-K0001213900-26-094389
Aug 13, 20266-K0001213900-26-088851
Aug 6, 20266-K0001213900-26-086007
Jul 31, 20266-K0001213900-26-083987
Jul 31, 20266-K0001213900-26-083984
Jul 31, 2026EFFECT9999999995-26-002505
Jul 30, 2026F-3/A0001213900-26-083328
Jul 22, 20266-K0001213900-26-080203
Jun 29, 20266-K0001213900-26-072907
Jun 25, 20266-K0001213900-26-071799
Jun 17, 202640001213900-26-069662
Jun 17, 202640001213900-26-069663
Jun 11, 20266-K0001213900-26-067577
Jun 9, 20266-K0001213900-26-066582
Jun 8, 20266-K0001213900-26-066077
Apr 28, 20266-K0001213900-26-048513
Apr 24, 20266-K0001213900-26-047292
Apr 6, 20266-K0001213900-26-040185
Apr 3, 20266-K0001213900-26-039734
Apr 1, 202630001213900-26-038542
Apr 1, 202640001213900-26-038545
Mar 31, 20266-K0001213900-26-036972
Mar 31, 202630001213900-26-037462
Mar 31, 202620-F0001213900-26-036970